PROGRAM

Conference

Check

List
Innovative Therapeutics
May 10 (Fri) 09:30~12:20, Rm.307
Session 7. Global Trends in Cancer Vaccines for Prevention and Treatment, and the Current Position and Development Strategies of Domestic Cancer Vaccines
    The background for preparing a session on cancer vaccines for prevention and treatment in the field of 'Innovative Therapeutic Technologies' at this conference is due to the remarkable advancements made in the medical and scientific communities in recent years. Cancer vaccines provide an innovative approach to cancer prevention and treatment, establishing themselves as a crucial area, particularly in the perspective of personalized medicine. The primary objective of this session is to analyze the development status of cancer vaccines both domestically and internationally, and to explore the potential future developments within our country. Through this, participants will gain an understanding of the latest research trends and have opportunities for knowledge sharing and collaboration with experts from both within the country and abroad.
  • Session Chair
  • Joo Sung Yang Senior Vice President, Head of Biotech RD, Biotechnology R&D, ST PHARM
  • Introduction of the Chair and Welcoming Remarks
  • 09 : 30 ~ 09 : 40
  • Advances in mRNA Sciences : The Design, Manufacture, and Use of mRNA Vaccines and Therapies
  • Rachel Yoon ChangFacility Lead, BASE mRNA Facility, The University of Queensland
  • 09 : 40 ~ 10 : 20
  • Current Status of Therapeutic Cancer Vaccine: From Discovery to Clinical Trial
  • Hun JungHead of R&D Division / M.D., Aston Research Institute, Aston sci.
  • 10 : 20 ~ 11 : 00
  • Things to consider in designing personalized cancer vaccines
  • Soonmyung PaikCEO/CTO, R&D Center, THERAGEN BIO
  • 11 : 00 ~ 11 : 40
  • mRNA Technology: From Vaccines to Cancer
  • Han Sol LeeMSL, Medical Affairs, Moderna Korea
  • 11 : 40 ~ 12 : 20
 

BIO KOREA 2024 PARTNERS

BIO KOREA 2024 SPONSORS